Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of APVO will decline by -7.06% over the next 2 Weeks and hit $0.86 by Wednesday, January 7, 2026. In that time frame, APVO's share price is expected to range between $0.74 and $0.99.
BearishAverageBullishAPVO shares fell -36.46% in Friday, December 26, 2025's trading session, dropping from a previous close of $0.93 to move at $0.59. The stock demonstrated notable intraday movement (see APVO's key stats for a full breakdown), fluctuating between $0.50 and $0.69, a +36.90% trading range. While recent weeks have seen some volatility, APVO has managed to secure a -50.75% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 910.2K shares changing hands, 309.05K more than the previous session. This amounted to $537.93K in total market activity.
Will APVO Continue Its Upward Trend?
According to analyst ratings and projections for APVO, Aptevo Therapeutics Inc. shares are anticipated to increase by +37.42%, potentially reaching $0.94 per share by January 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for APVO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the APVO stock forecast, now is a good time to buy APVO stock because its current trading price is -27.93% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on APVO covering social and institutional perspectives.
APVO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into APVO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 15.89% to 26.84%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 35.93%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 39.01%, signals a bearish bias in the long-term trend. Insights into APVO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aptevo Therapeutics Short-Term Forecasts
APVO Forecast For Next 5 Days
Our algorithm anticipates Aptevo Therapeutics (APVO) stock could hit $1.01 by Jan 02, 2026. This represents a +70.46% fall from today's price, following a -15.45% change over the past five days.
APVO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aptevo Therapeutics Inc. (APVO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.89, which would mean a +50.59% increase from the current price of $0.59. Projections for this period range from a high of $1.13 to a low of $0.60.
APVO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aptevo Therapeutics's price over the next three months point to a drop. APVO stock is expected to peak at $1,005.64 on Feb 26, 2026 before potentially dipping to $0.00 on Mar 26, 2026. On average, APVO is likely to trade around $0.46 in the coming 90 days.
Aptevo Therapeutics Stock Forecast 2025
Based on our predictive models, Aptevo Therapeutics (APVO) is expected to trade between $0.00 and $839.20 throughout 2025. This would result in an average price of $0.53, potentially offering investors a -10.32% return from current levels.
Aptevo Therapeutics Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Aptevo Therapeutics Inc. (APVO) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.00 and $839.20, settling at an average of $0.53. This could translate to a -10.32% loss.
January 2026
Based on current market signals, Aptevo Therapeutics Inc. is projected to trend january 2026. We forecast a trading range from $0.00 to $945.62, with a likely average price of $0.60. Investors could expect a potential return of +1.52%.
February 2026
Our predictive algorithms indicate Aptevo Therapeutics Inc. stock may see a shift in February 2026. The expected range spans $0.00–$1005.64, with an average target of $0.42. This represents a cautious outlook and a possible loss of -28.93%.
March 2026
Analyzing established trends, Aptevo Therapeutics Inc. looks set to move in March 2026. Projections place the stock between $0.00 and $911.86, averaging around $0.33. This suggests a -44.16% loss from current levels.
April 2026
Market indicators suggest Aptevo Therapeutics Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $889.94, with a midpoint forecast of $0.18. The stock might deliver a -69.54% loss.
May 2026
Forecasting for May 2026, models estimate that Aptevo Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $998.55, averaging $0.15. This signals a cautious trajectory with potential returns around -74.62%.
June 2026
According to our latest forecast models, Aptevo Therapeutics Inc. (APVO) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $907.23, settling at an average of $0.14. This could translate to a -76.31% loss.
July 2026
Based on current market signals, Aptevo Therapeutics Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $908.48, with a likely average price of $0.10. Investors could expect a potential return of -83.08%.
August 2026
Our predictive algorithms indicate Aptevo Therapeutics Inc. stock may see a shift in August 2026. The expected range spans $0.00–$895.40, with an average target of $0.04. This represents a cautious outlook and a possible loss of -93.23%.
September 2026
Analyzing established trends, Aptevo Therapeutics Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $886.31, averaging around $0.01. This suggests a -98.31% loss from current levels.
October 2026
Market indicators suggest Aptevo Therapeutics Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $962.47, with a midpoint forecast of $0.02. The stock might deliver a -96.62% loss.
November 2026
Forecasting for November 2026, models estimate that Aptevo Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $888.83, averaging $0.01. This signals a cautious trajectory with potential returns around -98.31%.
December 2026
According to our latest forecast models, Aptevo Therapeutics Inc. (APVO) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $986.87, settling at an average of $0.01. This could translate to a -98.31% loss.
APVO's history of dividends and stock splits also plays a role in long-term investor confidence.